Senti Biosciences Completes Merger With Dynamics Special Purpose Corp.

CFGI’s Capital Markets team assisted Senti Biosciences, Incorporated (“Senti Bio”) with the completion of its merger with Dynamics Special Purpose Corporation (“DYNS”) (Nasdaq: DYNS), a special purpose acquisition company.

More

BCP Raptor Holdco LP Completes Reverse Merger With Altus Midstream Company

CFGI’s Capital Markets team assisted privately-owned BCP Raptor Holdco LP (“BCP”), the parent company of EagleClaw Midstream, with the completion of an all-stock business combination with Altus Midstream Company (Nasdaq: ALTM) (“Altus”), creating a unique, fully-integrated midstream company.

More

2021 Year in Review

2021 was a year of tremendous change and growth for CFGI.

More

Capital Markets Advisory: 2021 Year in Review

2021 was an exciting year of growth for CFGI, which included a new partnership with CVC Capital Partners, one of the world’s largest private equity firms.

More

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

CFGI Celebrates Largest Promotion Class for 2022

2021 was an exciting year for CFGI; we announced a new partnership with CVC alongside current partner The Carlyle Group, saw significant growth in the business and can now announce the largest promotion class to date.

More

Enjoy Technology Completes Business Combination With Marquee Raine Acquisition Corp.

CFGI’s Capital Markets team assisted Enjoy Technology, Inc.

More

CFGI and Carlyle Partner with CVC Capital Partners

We’re excited to announce that CVC Capital Partners, one of the world’s largest private equity firms, will join forces with CFGI and The Carlyle Group to continue to propel the firm in our mission to be the world’s leading non-audit accounting and finance advisory firm.

More

atai Life Sciences Launches Initial Public Offering

CFGI’s Capital Markets team supported atai Life Sciences B.

More